Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 39, 3080-3088, August 1, 1979]
© 1979 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ball, J. K.
Right arrow Articles by McCarter, J. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ball, J. K.
Right arrow Articles by McCarter, J. A.

Biological Characterization of a Leukemogenic Virus Isolated from the CFW Mouse1

J. K. Ball2 and J. A. McCarter

Cancer Research Laboratory, University of Western Ontario, London, Ontario, Canada N6A 5B7

Extracts of thymic lymphomas induced by dimethylbenz(a)-anthracene are leukemogenic when injected into intrarenal thymic grafts. Tumor cell lines established in vitro from tumors induced by such extracts were found to release virus with the properties of a C-type particle. This tissue culture-derived virus (virus produced by tissue culture cell lines established from tumors induced by cell-free tumor extracts or tissue culture cell supernatants) is highly leukemogenic (minimum infectious titer of 1.6 x 106 IU/ml) when injected into a 24-hr-old thymus graft placed under the kidney capsule of a normal 6-week-old adult. The latent period (time in days to tumor detection in 50% of the injected grafts using undiluted tissue culture virus preparations) is very short (30 days postinjection). Thymic lymphomas induced by both virus isolated from dimethylbenz(a)anthracene-induced tumor virus cells and virus produced by tissue culture cell lines established from tumors induced by cell-free tumor extracts or tissue culture cell supernatants have been characterized as T-cell thymomas. Productive infection with either of the viral isolates could not be initiated on any of a wide variety of tissue culture cell lines under conditions that readily permitted the recovery of xenotropic and ecotropic type C viruses in control experiments. The data indicate that, unlike radiation leukemia virus, the leukemogenic virus produced by tissue culture cell lines established from tumors induced by cell-free tumor extracts or tissue culture cell supernatants does not infect cell lines in culture. Unlike radiation leukemia virus, virus isolated from dimethylbenz(a)anthracene-induced tumor virus cells does not appear to be accompanied by detectable and/or recoverable levels of xenotropic or ecotropic type C viruses.

The leukemogenic virus produced by the established tumor cell lines has a buoyant density and RNA genome characteristic of C-type particles. Polyacrylamide-sodium dodecyl sulfate gel analysis of the viral proteins indicated a markedly altered pattern of gag-coded proteins compared to those of the xenotropic virus induced from a lymphoid-derived cell line established from CFW/D mice.

1 This is Paper 1 of the series. Supported by the National Cancer Institute of Canada.

2 To whom requests for reprints should be addressed, at Cancer Research Laboratory, University of Western Ontario, London, Ontario, Canada N6A 5B7.

Received 6/21/78. Accepted 5/ 8/79.




This article has been cited by other articles:


Home page
J. Virol.Home page
F. Mustafa, S. Bhadra, D. Johnston, M. Lozano, and J. P. Dudley
The Type B Leukemogenic Virus Truncated Superantigen Is Dispensable for T-Cell Lymphomagenesis
J. Virol., March 15, 2003; 77(6): 3866 - 3870.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. R. Broussard, J. A. Mertz, M. Lozano, and J. P. Dudley
Selection for c-myc Integration Sites in Polyclonal T-Cell Lymphomas
J. Virol., March 1, 2002; 76(5): 2087 - 2099.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1979 by the American Association for Cancer Research.